Knockdown of pre-existing iNOS using siRNA or shRNA methodology has been shown to attenuate the growth and expansion of malignancies [16,17,18], thereby substantiating iNOS/NO’s tumor-supporting role. This evidence concerns the gene NOS2 and neoplasm.